Budget impact of Tirabrutinib
1 evidence topic · 1 source
Summary
The report contains a Japanese receipt-score-based tirabrutinib treatment cost of 0.91 million JPY per month. This is not a U.S. average sales price, wholesale acquisition cost, or population-level budget impact estimate. No tirabrutinib-specific budget impact model was identified.